Additionally, the BSD
-2000 has Humanitarian Device Exemption (HDE) marketing approval from the US FDA for use in conjunction with radiation therapy for the treatment of cervical cancer patients who are ineligible for chemotherapy as well as CE (Conformite Europeenne) marking approval in Europe, concluded BSD
In 2011, BSD
Medical obtained humanitarian device exemption marketing approval for the BSD
-2000 from the U.
achieved its goals using Cisco solutions for IP statistical multiplexing, encoding and management.
The FreeBSD group was originally started to focus on running BSD
using the standard Intel x86 architecture--the same PCs that usually run Windows.
By the third quarter of this year, 55% of all responding organizations will have deployed at least one Linux or BSD
Jim has a great background of success in promoting medical devices in the Latin American market, and we feel that he will help establish BSD
Medical as a solid player in that market, where there is a great need for our products.
Developed and patented exclusively by BSD
, the BSD
-2000 delivers localised therapeutic heating (hyperthermia) by applying radiofrequency (RF) energy.
21 November 2011 - US medical systems provider BSD
Medical Corporation (NASDAQ:BSDM) said today it had received Humanitarian Device Exemption (HDE) marketing approval for the BSD
-2000 hyperthermia system (BSD
-2000) from the US Food and Drug Administration (FDA).
SALT LAKE CITY -- BSD
Medical Corporation (NASDAQ:BSDM) (the "Company" or "BSD
") announced today that Horizon Medical Services (Horizon) in Tamarac, Florida has purchased a BSD
-500 Hyperthermia System (BSD
Bill has proven outstanding competency and experience in all areas of senior corporate financial management in public and privately held medical device companies and understands the unique characteristics associated within that industry," said Harold Wolcott, BSD
President and CEO.
Exhibiting at ASTRO allowed BSD
to showcase the Company's hyperthermia technology to interested physicians and distributors throughout the world," stated Harold R.
SALT LAKE CITY -- BSD
Medical Corporation (NASDAQ: BSDM) today announced that the German Society of Radiation Oncology (DEGRO) has published quality assurance guidelines for deep hyperthermia that support the advanced phased array technology utilized in the BSD
-2000 Hyperthermia System.